Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium)

key information

study id #: NCT04419233

condition: Muscular Atrophy, Spinal

status: Recruiting


The primary objective of this study is to evaluate the safety of nusinersen sodium injection in the postmarketing setting in China.The secondary objectives are to collect data on the efficacy and the pharmacokinetics of nusinersen sodium injection in the post-marketing setting in China.

intervention: Nusinersen Sodium Injection


last updated: March 03, 2022